Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00743327 · ClinicalTrials.gov registry record
Androgen Deprivation Therapy Study
A clinical trial, sponsored by National Institute on Aging (NIA).
- Terminated
- Registry status
- 1
- Enrollment target
NCT00743327 is a clinical trial that was terminated before completion, run by National Institute on Aging (NIA). The registered enrollment target is 1 participants.
The verdict
NCT00743327 was terminated before completion, sponsored by National Institute on Aging (NIA).
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the link between low testosterone and insulin resistance/diabetes in men undergoing androgen deprivation therapy for prostate cancer. The study will also evaluate other cardiovascular risk factors in these men.
Interventions
- DRUG Pioglitazone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-10 |
| Est. Completion | 2012-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00743327
The ClinicalTrials.gov registry entry for NCT00743327 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pioglitazone is the first listed.
NCT00743327 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00743327 about?
NCT00743327 is a clinical study titled "Androgen Deprivation Therapy Study". The purpose of this study is to examine the link between low testosterone and insulin resistance/diabetes in men undergoing androgen deprivation therapy for prostate cancer. The study will also evaluate other cardiovascular risk factors in these men.
What is the current status of trial NCT00743327?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2008-10. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00743327?
The interventions under investigation include: Pioglitazone (DRUG).
Who is sponsoring clinical trial NCT00743327?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.